Fermenta Biotech Ltd.
Snapshot View

168.75 -7.10 ▼-4.0%

27 January 2023, 04:01:00 PM
Volume: 13,321

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.fermentabiotech.com
Market Cap 499.00 Cr.
Enterprise Value(EV) 698.79 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -3.64 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 32.90 Trailing Twelve Months Ending 2022-09
Book Value / Share 121.80 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.39 Calculated using Price: 168.75
Dividend Yield 0.74 Period Ending 2022-03
No. of Shares Subscribed 2.94 Cr. 29,430,987 Shares
FaceValue 5
Company Profile
Currently, DIL is engaged in the business of research support services through its subsidiary Research Support International Ltd. (RSIL), manufacture and marketing of enzymes and chemicals through its subsidiary Fermenta Biotech Ltd. (FBL), entertainment through its subsidiary White Stripes Entertainment Ltd. (WSEL) and manufacture and marketing of levitation technology and wheel chairs through its Joint Venture company, being set up in the Czech Republic.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-4.04%
1 Week
-4.61%
1 Month
-4.50%
3 Month
-13.73%
6 Month
-12.81%
1 Year
-40.57%
2 Year
-42.12%
5 Year
-23.23%
10 Year
+261.58%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 8.47 0.72 2.08 -6.00 40.79 64.77 21.92 13.05 4.27
Return on Capital Employed (%) 10.54 3.68 6.18 1.96 33.86 40.16 12.98 12.62 7.50
Return on Assets (%) 4.55 0.37 0.99 -2.76 15.85 25.73 10.75 6.56 2.04

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 133 132 130 144 124 251 309 361 372 358
Non Curr. Liab. 33 14 24 48 146 125 72 131 154 112
Curr. Liab. 71 94 108 86 104 156 195 230 228 203
Minority Int. 22 22 26 28 11 0 0 0 -1 -1
Equity & Liab. 259 262 288 307 385 532 576 722 753 671
Non Curr. Assets 145 171 195 203 202 226 292 391 419 367
Curr. Assets 114 91 93 104 182 296 284 330 335 304
Misc. Exp. not W/O 10
Total Assets 259 262 288 307 385 532 576 722 753 671

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 139 142 155 164 303 405 293 377 399 379
Other Income 3 0 1 3 11 27 14 8 8 11
Total Income 142 142 156 167 314 431 307 386 407 390
Total Expenditure -113 -126 -135 -152 -212 -269 -229 -295 -336 -351
PBIDT 30 16 21 15 102 162 79 91 70 39
Interest -5 -5 -6 -10 -14 -21 -20 -19 -18 -18
Depreciation -10 -9 -8 -10 -12 -12 -15 -20 -26 -29
Taxation -3 -2 -4 -3 -21 -11 16 -9 -12 -4
Exceptional Items
PAT 11 1 3 -8 55 118 60 43 15 -12
Minority Interest -2 0 -3 -3 -13 0 0 3 0 1
Share Associate -1 0 -1 0 -8 0
Other Related Items
Consolidated Net Profit 8 0 -1 -11 34 117 60 46 15 -11
Adjusted EPS 3 0 0 -4 12 43 21 16 5 -4

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 23 14 15 4 2 59 90 34 63 43
Cash Fr. Inv. -20 -25 -18 -13 7 -101 -97 -44 -42 -26
Cash Fr. Finan. -8 13 1 10 -12 89 12 -47 -1 -22
Net Change -4 2 -2 1 -4 47 6 -57 20 -4
Cash & Cash Eqvt 4 6 3 5 -15 32 38 -18 2 -2

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 59.44 59.44 59.44 59.44 59.58 59.58 59.58 59.58 59.58
Public 40.56 40.56 40.56 40.55 40.42 40.41 40.42 40.41 40.42
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 26 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we inform you that the Company has received information from the shareholder about loss of share certificates on January 25 2023
Wed, 18 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we inform you that the Company has received an intimation from its Registrar and Transfer Agent - Link Intime India Private Limited on January 17 2023 regarding issue of duplicate share certificate to the shareholder.
Tue, 17 Jan 2023
Execution Of Sale Deed
Further to our earlier intimation dated June 9 2022 in relation to the members approval obtained to sell lease or otherwise dispose of the portion of Companys assets being premises located in Thane One Building DIL Complex Ghodbunder Road Majiwade Thane (West) 400 610 we wish to inform you that the Company has executed and registered a sale deed on January 17 2023 to sell premises situated at the 7th floor in Thane One Building DIL Complex Ghodbunder Road Majiwade Thane (West) 400 610 on the terms and conditions mentioned in the sale deed and as approved by the Board of Directors of the Company.The information regarding the aforesaid sale of premises is provided in Annex-A herewith.This intimation is given under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for your records.

Technical Scans View Details >>

Fri, 27 Jan 2023
Higher Trade Quantity Higher Trade Quantity
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Low Close Crossing Last Month Low
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Close Crossing 52 Week Low Close Crossing 52 Week Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Fermenta Biotech Ltd.

What is Fermenta Biotech share price?

Can I buy Fermenta Biotech shares now?

What is the Dividend Yield of Fermenta Biotech?

What is the Market Cap of Fermenta Biotech?

What are the key metrics to analyse Fermenta Biotech?

What is the 52 Week High and Low of Fermenta Biotech?

What is the trend of Fermenta Biotech share price?